Osimertinib (AZD-9291) is an EGFR third-generation inhibitor that inhibits the T790M resistance mutation produced by second-generation EGFR inhibitors with irreversible and oral activity. Osimertinib has antitumor activity for the treatment of EGFR-mutated non-small-cell lung cancer.
Molecular Weight:
499.61
Purity:
>99.99%
CAS Number:
[1421373-65-0]
Formula:
C28H33N7O2
Target:
EGFR
T2490
* VAT and and shipping costs not included. Errors and price changes excepted
